Lineage Cell Therapeutics Statistics
Total Valuation
LCTX has a market cap or net worth of $275.17 million. The enterprise value is $238.46 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
LCTX has 228.36 million shares outstanding. The number of shares has increased by 22.42% in one year.
Current Share Class | 228.36M |
Shares Outstanding | 228.36M |
Shares Change (YoY) | +22.42% |
Shares Change (QoQ) | +1.02% |
Owned by Insiders (%) | 0.42% |
Owned by Institutions (%) | 20.94% |
Float | 177.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 24.69 |
Forward PS | 14.70 |
PB Ratio | 5.76 |
P/TBV Ratio | 46.33 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 21.85 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.05.
Current Ratio | 4.08 |
Quick Ratio | 3.96 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.51% and return on invested capital (ROIC) is -21.41%.
Return on Equity (ROE) | -71.51% |
Return on Assets (ROA) | -13.17% |
Return on Invested Capital (ROIC) | -21.41% |
Return on Capital Employed (ROCE) | -25.48% |
Revenue Per Employee | $141,740 |
Profits Per Employee | -$531,299 |
Employee Count | 77 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.22% in the last 52 weeks. The beta is 1.67, so LCTX's price volatility has been higher than the market average.
Beta (5Y) | 1.67 |
52-Week Price Change | +38.22% |
50-Day Moving Average | 1.06 |
200-Day Moving Average | 0.70 |
Relative Strength Index (RSI) | 59.42 |
Average Volume (20 Days) | 1,523,337 |
Short Selling Information
The latest short interest is 26.76 million, so 11.72% of the outstanding shares have been sold short.
Short Interest | 26.76M |
Short Previous Month | 28.09M |
Short % of Shares Out | 11.72% |
Short % of Float | 15.05% |
Short Ratio (days to cover) | 16.01 |
Income Statement
In the last 12 months, LCTX had revenue of $10.91 million and -$40.91 million in losses. Loss per share was -$0.19.
Revenue | 10.91M |
Gross Profit | -2.17M |
Operating Income | -20.40M |
Pretax Income | -24.19M |
Net Income | -40.91M |
EBITDA | -19.77M |
EBIT | -20.40M |
Loss Per Share | -$0.19 |
Full Income Statement Balance Sheet
The company has $42.29 million in cash and $2.15 million in debt, giving a net cash position of $40.13 million or $0.18 per share.
Cash & Cash Equivalents | 42.29M |
Total Debt | 2.15M |
Net Cash | 40.13M |
Net Cash Per Share | $0.18 |
Equity (Book Value) | 47.11M |
Book Value Per Share | 0.21 |
Working Capital | 33.09M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$22.56 million and capital expenditures -$588,000, giving a free cash flow of -$23.15 million.
Operating Cash Flow | -22.56M |
Capital Expenditures | -588,000 |
Free Cash Flow | -23.15M |
FCF Per Share | -$0.10 |
Full Cash Flow Statement Margins
Gross Margin | -19.86% |
Operating Margin | -186.87% |
Pretax Margin | -373.45% |
Profit Margin | n/a |
EBITDA Margin | -181.13% |
EBIT Margin | -186.87% |
FCF Margin | n/a |
Dividends & Yields
LCTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.42% |
Shareholder Yield | -22.42% |
Earnings Yield | -14.68% |
FCF Yield | -8.31% |
Dividend Details Analyst Forecast
The average price target for LCTX is $4.25, which is 252.70% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.25 |
Price Target Difference | 252.70% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 57.08% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on October 31, 1997. It was a forward split with a ratio of 3:1.
Last Split Date | Oct 31, 1997 |
Split Type | Forward |
Split Ratio | 3:1 |
Scores
LCTX has an Altman Z-Score of -4.91 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.91 |
Piotroski F-Score | 4 |